Results 141 to 150 of about 19,155 (194)

Jumonji histone demethylases are therapeutic targets in small cell lung cancer. [PDF]

open access: yesOncogene
Nguyen A   +11 more
europepmc   +1 more source

Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer. [PDF]

open access: yesClin Epigenetics
Chen D   +9 more
europepmc   +1 more source

α-Ketoglutarate-Dependent KDM6 Histone Demethylases and Interferon-Stimulated Gene Expression in Lupus. [PDF]

open access: yesArthritis Rheumatol
Montano EN   +18 more
europepmc   +1 more source

Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer. [PDF]

open access: yesTheranostics, 2020
Zhang J   +11 more
europepmc   +1 more source

Structure-Based Screening of Tetrazolylhydrazide Inhibitors versus KDM4 Histone Demethylases. [PDF]

open access: yesChemMedChem, 2019
Małecki PH   +7 more
europepmc   +1 more source

Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer. [PDF]

open access: yesCancers (Basel), 2019
Benedetti R   +21 more
europepmc   +1 more source

Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox. [PDF]

open access: yesCancer Res, 2017
Yang J   +30 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy